NCT06541990 Psychoeducational Intervention for Patients With Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06540508 Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma Status ENROLLING_BY_INVITATION Phase N/A
NCT06538935 SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06537908 Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC Status RECRUITING Phase N/A
NCT06537193 Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment Status RECRUITING Phase NA
NCT06530251 A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC) Status RECRUITING Phase PHASE1/PHASE2
NCT06527495 Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT06526338 Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone Status RECRUITING Phase PHASE2
NCT06526104 Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis Status RECRUITING Phase PHASE2
NCT06523608 Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease Status RECRUITING Phase N/A
NCT06519721 Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC Status ACTIVE_NOT_RECRUITING Phase NA
NCT06519578 Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06518434 A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients Status RECRUITING Phase PHASE2
NCT06512467 Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06508307 A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06503146 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection Status RECRUITING Phase PHASE2
NCT06498622 Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab Status RECRUITING Phase PHASE2
NCT06496113 Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT06482008 HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study Status NOT_YET_RECRUITING Phase PHASE2